Myia Labs is a San Francisco startup that offers a remote patient-monitoring platform for chronic disease management, especially heart failure. Its technology ingests data from clinical and commercial devices including Apple Watch, Fitbit and the Motiv Ring, plus home equipment such as sleep sensors, connected scales, wearables and tablets, to track vitals like respiratory rate, heart rate, blood pressure and weight. The platform analyzes and parses the data to provide clinicians with early warnings of clinical deterioration, support medication titration, and help optimize care and visit planning. Myia was founded last year and recently raised $6.75 million in seed funding to advance product development and clinical validation. The company is in a multi-site trial with UCSF and running pilots with providers to build datasets and validate its predictive algorithms ahead of regulatory submission. It emphasizes explainable AI to promote clinical trust and has partnered with the American College of Cardiology for both investment and clinical input; CMS reimbursement changes are cited as an industry tailwind.

Total raised

$7M

Funding rounds

1

Latest round

Seed

Latest activity

Dec 2018